These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 1975782

  • 1. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K, Karcz M, Wardas J, Wolfarth S.
    Eur J Pharmacol; 1990 Jul 03; 182(2):327-34. PubMed ID: 1975782
    [Abstract] [Full Text] [Related]

  • 2. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J, Pietraszek M, Ossowska K, Wolfarth S.
    Pol J Pharmacol; 1995 Jul 03; 47(4):349-53. PubMed ID: 8616516
    [Abstract] [Full Text] [Related]

  • 3. Lateral hypothalamus-zona incerta region as an output station for the catalepsy induced by the blockade of striatal D1 and D2 dopamine receptors.
    Ossowska K, Wardas J, Golembiowska K, Wolfarth S.
    Brain Res; 1990 Jan 08; 506(2):311-5. PubMed ID: 2154287
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain.
    Merchant KM, Bush LG, Gibb JW, Hanson GR.
    Brain Res; 1989 Oct 23; 500(1-2):21-9. PubMed ID: 2532557
    [Abstract] [Full Text] [Related]

  • 5. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA, Szczepanik AM.
    Brain Res; 1989 May 22; 487(2):288-98. PubMed ID: 2525063
    [Abstract] [Full Text] [Related]

  • 6. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF, Sanberg PR, Norman AB.
    Brain Res; 1988 May 31; 450(1-2):403-7. PubMed ID: 2969764
    [Abstract] [Full Text] [Related]

  • 7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 31; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 8. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
    Neisewander JL, O'Dell LE, Redmond JC.
    Brain Res; 1995 Feb 13; 671(2):201-12. PubMed ID: 7743209
    [Abstract] [Full Text] [Related]

  • 9. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study.
    Moghaddam B, Bunney BS.
    J Neurochem; 1990 May 13; 54(5):1755-60. PubMed ID: 1969939
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of dopamine antagonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats.
    Yamada S, Takaki T, Yokoo H, Tanaka M.
    J Pharm Pharmacol; 1995 Mar 13; 47(3):259-62. PubMed ID: 7602493
    [Abstract] [Full Text] [Related]

  • 11. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA, Bush LG, Gibb JW, Hanson GR.
    Brain Res; 1992 Feb 07; 571(2):260-4. PubMed ID: 1351780
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
    Ozer H, Ekinci AC, Starr MS.
    Brain Res; 1997 Nov 28; 777(1-2):51-9. PubMed ID: 9449412
    [Abstract] [Full Text] [Related]

  • 13. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
    Memo M, Pizzi M, Missale C, Carruba MO, Spano PF.
    Neuropharmacology; 1987 May 28; 26(5):477-80. PubMed ID: 2955241
    [Abstract] [Full Text] [Related]

  • 14. SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum.
    Wardas J, Pietraszek M, Dziedzicka-Wasylewska M.
    Brain Res; 2003 Jul 11; 977(2):270-7. PubMed ID: 12834887
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D1 receptors in the nucleus accumbens: involvement in the reinforcing effect of tegmental stimulation.
    Kurumiya S, Nakajima S.
    Brain Res; 1988 May 10; 448(1):1-6. PubMed ID: 2968828
    [Abstract] [Full Text] [Related]

  • 16. Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens.
    Merchant KM, Gibb JW, Hanson GR.
    Eur J Pharmacol; 1989 Feb 07; 160(3):409-12. PubMed ID: 2565819
    [Abstract] [Full Text] [Related]

  • 17. Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats.
    Maldonado R, Daugé V, Feger J, Roques BP.
    Neuropharmacology; 1990 Mar 07; 29(3):215-23. PubMed ID: 2157999
    [Abstract] [Full Text] [Related]

  • 18. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
    Govoni S, Lucchi L, Missale C, Memo M, Spano PF, Trabucchi M.
    Brain Res; 1986 Aug 27; 381(1):138-42. PubMed ID: 3756492
    [Abstract] [Full Text] [Related]

  • 19. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
    Dreher JK, Jackson DM.
    Brain Res; 1989 May 22; 487(2):267-77. PubMed ID: 2525062
    [Abstract] [Full Text] [Related]

  • 20. Cooperation between D1- and D2-dopamine receptors in the nucleus accumbens.
    Szmigielski A, Zalewska-Kaszubska J.
    Neuropharmacology; 1991 Mar 22; 30(3):259-66. PubMed ID: 1830133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.